Early Alzheimer's disease pathology in human cortex involves transient cell states

Cell. 2023 Sep 28;186(20):4438-4453.e23. doi: 10.1016/j.cell.2023.08.005.

Abstract

Cellular perturbations underlying Alzheimer's disease (AD) are primarily studied in human postmortem samples and model organisms. Here, we generated a single-nucleus atlas from a rare cohort of cortical biopsies from living individuals with varying degrees of AD pathology. We next performed a systematic cross-disease and cross-species integrative analysis to identify a set of cell states that are specific to early AD pathology. These changes-which we refer to as the early cortical amyloid response-were prominent in neurons, wherein we identified a transitional hyperactive state preceding the loss of excitatory neurons, which we confirmed by acute slice physiology on independent biopsy specimens. Microglia overexpressing neuroinflammatory-related processes also expanded as AD pathology increased. Finally, both oligodendrocytes and pyramidal neurons upregulated genes associated with β-amyloid production and processing during this early hyperactive phase. Our integrative analysis provides an organizing framework for targeting circuit dysfunction, neuroinflammation, and amyloid production early in AD pathogenesis.

Keywords: Alzheimer’s disease; amyloid pathology; disease systems biology; human cortex; meta-analysis; microglia disease response; neuronal hyperactivity; single-nucleus RNA sequencing; β-amyloid metabolism.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Alzheimer Disease* / metabolism
  • Alzheimer Disease* / pathology
  • Amyloid
  • Amyloid beta-Peptides / metabolism
  • Biopsy
  • Cell Nucleus / metabolism
  • Cell Nucleus / pathology
  • Frontal Lobe* / pathology
  • Humans
  • Microglia* / pathology
  • Neurons* / pathology
  • Pyramidal Cells
  • Single-Cell Gene Expression Analysis

Substances

  • Amyloid
  • Amyloid beta-Peptides